Internal Medicine, Rheumatology · Panama City, FL
NPI
1831381789
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2232 W 24th St
Panama City, FL, 32405
Phone (850) 215-3062
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.8M
428,001 services
Medicare patients, 2024
1,066
Average age 73
Drug cost, 2024
$4.1M
4,544 prescriptions
Company payments, 2025
$1,372
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir B Agha was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 166,805 times for 59 patients. In total Amir B Agha billed 428,001 services in 56 codes, and Medicare paid $4.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 166,805 | 59 | $3.63 | $605K |
| J3262 Injection, tocilizumab, 1 mg | Office | 93,052 | 24 | $4.69 | $436K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 45,992 | 72 | $33.71 | $1.6M |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 35,017 | 46 | $8.95 | $313K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 16,807 | 26 | $8.34 | $140K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 12,260 | 131 | $0.10 | $1,241 |
| J0897 Injection, denosumab, 1 mg | Office | 11,701 | 160 | $20.34 | $238K |
| J9312 Injection, rituximab, 10 mg | Office | 4,354 | 17 | $59.96 | $261K |
| 96401 Chemotherapy Administration | Office | 1,174 | 236 | $52.94 | $62K |
| 97110 PT Treatment | Office | 1,116 | 168 | $17.77 | $20K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,073 | 45 | $0.23 | $243 |
| 97140 PT Treatment | Office | 1,031 | 162 | $16.68 | $17K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 999 | 274 | $43.99 | $44K |
| 97112 PT Treatment | Office | 971 | 153 | $21.38 | $21K |
| 97530 PT Treatment | Office | 872 | 160 | $27.81 | $24K |
By year: 2022 $3.0M for 198,234 services; 2023 $4.0M for 344,250 services; 2024 $4.8M for 428,001 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 25 | $4.90 | $127 |
Medicare prescription drug claims, 2024
In 2024, the drug Amir B Agha prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 717 prescriptions and refills. In total Amir B Agha wrote 4,544 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 717 | 1,365 | 250 | $25K |
| Prednisone Generic | 449 | 654 | 143 | $2,348 |
| Methotrexate Methotrexate Sodium | 326 | 619 | 120 | $5,976 |
| Pregabalin Generic | 278 | 367 | 83 | $9,576 |
| Meloxicam Generic | 276 | 439 | 116 | $1,167 |
| Gabapentin Generic | 276 | 546 | 109 | $3,609 |
| Tramadol Hcl Generic | 218 | 218 | 93 | $1,170 |
| Celecoxib Generic | 196 | 330 | 79 | $4,830 |
| Duloxetine Hcl Generic | 181 | 338 | 80 | $5,322 |
| Diclofenac Sodium Generic | 110 | 173 | 49 | $2,125 |
| Actemra Tocilizumab | 107 | 107 | Under 11 | $369K |
| Orencia Abatacept/Maltose | 104 | 104 | 11 | $511K |
| Folic Acid Generic | 93 | 177 | 35 | $465 |
| Prolia Denosumab | 69 | 414 | 49 | $122K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 67 | 67 | 18 | $967 |
Brand drugs: - claims; generic drugs: 3,899 claims; opioid claims: 285.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir B Agha $1,372 ($1,372 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $448.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 27 | $448 |
| Abbvie Inc. ABBV | 13 | $294 |
| GlaxoSmithKline, LLC. GSK | 7 | $178 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $141 |
| UCB, Inc. UCB.BR | 4 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45.78 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.33 |
| Organon LLC OGN | 1 | $25.76 |
| Tonix Medicines, Inc. | 1 | $25.47 |
| Bioventus LLC BVS | 1 | $21.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.